New medical devices deemed "breakthrough" by the FDA are no longer automatically eligible for extra Medicare payments.
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of ...
Amyloidsis, new treatment retrains cells to fight the disease.
SAN DIEGO, July 20, 2026--(BUSINESS WIRE)--On July 19th, pioneering medical technology company Xenco Medical unveiled its breakthrough XenVision technology, an AI-powered musculoskeletal intelligence ...
Scientists have announced a major milestone in synthetic biology, revealing they have successfully built a synthetic cell from scratch that can feed, grow and replicate much like a natural cell. While ...
VS3 Medical announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its VS3 System.
The baby had congenital pulmonary airway malformation (CPAM), a rare condition in which abnormal lung tissue develops during pregnancy.
Neola Medical AB (publ) today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Neola®, the Company’s medical device for non-invasive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results